Fresenius Medical Care Corporation is a medical care facilities business based in the US. Fresenius Medical Care Corporation shares (FMS) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $22.10 – an increase of 3.66% over the previous week. Fresenius Medical Care Corporation employs 113,079 staff and has a trailing 12-month revenue of around $19.2 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $22.10 |
|---|---|
| 52-week range | $17.80 - $22.12 |
| 50-day moving average | $20.60 |
| 200-day moving average | $20.06 |
| Wall St. target price | $21.15 |
| PE ratio | 17.6198 |
| Dividend yield | $1.19 (3.05%) |
| Earnings per share (TTM) | $1.21 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $22.1 from 2024-11-19
| 1 week (2024-11-14) | 3.66% |
|---|---|
| 1 month (2024-10-21) | 5.19% |
| 3 months (2024-08-21) | 16.38% |
| 6 months (2024-05-21) | 3.17% |
| 1 year (2023-11-21) | 12.47% |
|---|---|
| 2 years (2022-11-21) | 54.74% |
| 3 years (2021-11-19) | 28.9119 |
| 5 years (2019-11-21) | 32.5695 |
Valuing Fresenius Medical Care Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fresenius Medical Care Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fresenius Medical Care Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Fresenius Medical Care Corporation shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Fresenius Medical Care Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4277. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fresenius Medical Care Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fresenius Medical Care Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.4 billion.
The EBITDA is a measure of a Fresenius Medical Care Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $19.2 billion |
|---|---|
| Operating margin TTM | 8.32% |
| Gross profit TTM | $5.3 billion |
| Return on assets TTM | 2.98% |
| Return on equity TTM | 5.82% |
| Profit margin | 3.43% |
| Book value | $46.43 |
| Market Capitalization | $12.5 billion |
TTM: trailing 12 months
Dividend payout ratio: 42.58% of net profits
Recently Fresenius Medical Care Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fresenius Medical Care Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Fresenius Medical Care Corporation's case, that would currently equate to about $1.19 per share.
While Fresenius Medical Care Corporation's payout ratio might seem fairly standard, it's worth remembering that Fresenius Medical Care Corporation may be investing much of the rest of its net profits in future growth.
Fresenius Medical Care Corporation's most recent dividend payout was on 2 June 2024. The latest dividend was paid out to all shareholders who bought their shares by 16 May 2024 (the "ex-dividend date").
Fresenius Medical Care Corporation's shares were split on a 2:1 basis on 3 December 2012 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Fresenius Medical Care Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Fresenius Medical Care Corporation shares which in turn could have impacted Fresenius Medical Care Corporation's share price.
Over the last 12 months, Fresenius Medical Care Corporation's shares have ranged in value from as little as $17.8011 up to $22.1154. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Fresenius Medical Care Corporation's is 0.853. This would suggest that Fresenius Medical Care Corporation's shares are less volatile than average (for this exchange).
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany. .
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.